ПОЛИВАЛЕНТТИК БАКТЕРИАЛЫК ЛИЗАТТАРДЫН – ИСМИЖЕНДИН – ӨНӨКӨТТӨШКӨН ФАРИНГИТТЕРДИ ЖАНА ФАРИНГОТРАХЕИТТЕРДИ ДАРЫЛООДО КОЛДОНУУСУ
Аннотация
Өнөкөт фарингит жана өнөкөт фаринготрахеобронхиттин курчушу менен ооруган 97 бейтапты дарылоонун жыйын тыктарымакалада көрсөтүлгон. Клиникалык изилдөөлөрдүн негизинде Исмижен препаратын колдонуу менен гуморалдык жана клетка аркылуу негизделген иммунитеттин чындалышы жана стимуляциялануусу байкалат.
Ключові слова:
поливаленттүү бактериалдуу лизаттар, фарингит, фаринготрахеобронхит, исмижен.Посилання
1. Maul J. Stimullation of imunoprotective mechanisms by OM–85 BV. Respiration,1994, N 61 (Suppl. 1), P.8–15.
2. Braido F, Villa E, Schenone G, Canonica GW and Melioli G, A good clinical outcome therapy with a polyvalent mechanical bacterial lysate (PMBL) correlates with the capacity of inducing a speciэc locoregional immunoresponse in patients with recurrent upper respiratory tract infection, XXVII Congress of the European Academy of Allergology and Clinical Immunology, 2008.
3. Fuggetta MP and LanzilliG, Attivazion edelleris poste immunitarie mediantev accinibatterici, EurRespir News 15: pp69-77, 2007.
4. La Mantia I, Nicolosi F, Maiolino L and Serra A, Immunoprophylaxis of recurring bacterial infections of respiratory tracts in pediatric age: clinical experience through a new immuneоstimulating vaccine (It),GIMMOC, Quaderni di Microbiologia e Clinica XI: pp1-8, 2007.
5. Aksic OT, Cattaneo L and Rosaschino F, Evaluation of the clinical efэcacy of a new polyvalent bacterial lysate obtained by mechanical lysis (PMBL) in a population of 180 school-aged children with recurrent respiratory infections, European Journal of Aerobiology Environmental Medicine and Air-borne Infections 1: p1, 2005.
6. Villa E, Garelli V, Braido F, MelioliGandCanonica GW,; May we strengthen the human natural defenses with bacterial lysates. World Allergy Organization Journal 3(8): ppS17-S23, 2010.
7. Tricarico D, Varricchio A, D’Ambrosio S, Ascione E and Motta G, Prevention of recurrent upper respiratory tract infections in a community of cloistered nuns using a new immunostimulating bacterial lysate: a randomized, double-blind clinical trial, Arzneimittelforschung 54: pp57-63, 2004.
8. Cazzola M, A new bacterial lysate protects by reducing infectious exacerbations in moderate to very severe COPD: a double-blind, randomized, placebo controlled trial, Trends in Med 6: pp191-199, 2006;
9. Cazzola M, Noschese P and Di Perna F, Value of adding a polyvalent mechanical bacterial lysate to therapy of COPD patients under regular treatment with salmeterol / (uti-casone, Therapeutics Advances in Respiratory Diseases 3(2): pp59-63, 2009.
